N-Nitroso Nintedanib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Nintedanib is used to treat idiopathic pulmonary fibrosis. It helps prevent changes to the lung tissue. It is also used to treat people with a chronic (long-lasting) interstitial lung disease in which lung fibrosis continues to progress or becomes worse.N-Nitroso Nintedanib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nintedanib Impurity 1 CAS NO:NA Chemically represented as Methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate . Synchemia is the leading manufacturing and exporter of N-Nitroso Nintedanib Impurity 1 .We supply N-Nitroso Nintedanib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142084 |
| CAS No | NA |
| Mol.F. | C22H18N6O5S2 |
| Mol.Wt. | 510 .54g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142085 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O2 |
| Mol.Wt. | 300.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142086 |
| CAS No | NA |
| Mol.F. | C16H13N3O4 |
| Mol.Wt. | 311.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142087 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142088 |
| CAS No | NA |
| Mol.F. | C11H10N4O3S |
| Mol.Wt. | 278.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142089 |
| CAS No | NA |
| Mol.F. | C8H7N5O |
| Mol.Wt. | 189.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142090 |
| CAS No | 2619509-30-5 |
| Mol.F. | C9H10N2O3S |
| Mol.Wt. | 226.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142091 |
| CAS No | NA |
| Mol.F. | C9H21N3O |
| Mol.Wt. | 187.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142092 |
| CAS No | NA |
| Mol.F. | C17H16N6O3 |
| Mol.Wt. | 352.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142093 |
| CAS No | NA |
| Mol.F. | C5H10N2O5S |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142094 |
| CAS No | NA |
| Mol.F. | C4H10N204 |
| Mol.Wt. | 182.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142095 |
| CAS No | NA |
| Mol.F. | C18H27N3O5 |
| Mol.Wt. | 365.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142096 |
| CAS No | NA |
| Mol.F. | C15H18N2O5 |
| Mol.Wt. | 306.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142097 |
| CAS No | NA |
| Mol.F. | C16H23N3O5 |
| Mol.Wt. | 337.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142098 |
| CAS No | NA |
| Mol.F. | C12H14N2O4 |
| Mol.Wt. | 250.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142099 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |